Daidzin, a major active principle of an ancient Chinese herbal treatment (Radix puerariae) for
alcohol abuse, selectively suppresses
ethanol intake in all rodent models tested. It also inhibits
mitochondrial aldehyde dehydrogenase (ALDH-2). Studies on
ethanol intake suppression and ALDH-2 inhibition by structural analogs of
daidzin established a link between these two activities and suggested that
daidzin may suppress
ethanol intake by inhibiting ALDH-2. ALDH-2 is a principal
enzyme involved in
serotonin (5-HT) and
dopamine (DA) metabolism. Thus,
daidzin may act by inhibiting
5-HT and DA metabolism. To evaluate this possibility, we have studied the effect of
daidzin and its analogs on
5-HT and DA metabolism in isolated hamster and rat liver mitochondria.
Daidzin potently inhibits the formation of 5-hydroxyindole-3-acetic
acid (5-HIAA) and
3,4-dihydroxyphenylacetic acid (
DOPAC) from their respective
amines in isolated mitochondria. Inhibition is concentration-dependent and is accompanied by a concomitant accumulation of
5-hydroxyindole-3-acetaldehyde and 3, 4-dihydroxyphenylacetaldehyde.
Daidzin analogs that suppress hamster
ethanol intake also inhibit
5-HIAA and
DOPAC formation. Comparing their effects on mitochondria-catalyzed
5-HIAA or
DOPAC formation and hamster
ethanol intake reveals a positive correlation-the stronger the inhibition on
5-HIAA or
DOPAC formation, the greater the
ethanol intake suppression.
Daidzin and its active analogs, at concentrations that significantly inhibit
5-HIAA formation, have little or no effect on mitochondria-catalyzed
5-HT depletion. It appears that the antidipsotropic action of
daidzin is not mediated by
5-HT (or DA) but rather by its reactive intermediates
5-hydroxyindole-3-acetaldehyde and, presumably, 3, 4-dihydroxyphenylacetaldehyde as well, which accumulates in the presence of
daidzin.